Abstract:Background: Phosphatase and tensin homolog (PTEN) is an important tumor suppressor gene, and its encoded protein has activities of both a protein phosphatase and a lipid phosphatase. However, the substitution effect of protein phosphatase activity remains unclear. PI3K/Akt is the most common pathway negatively regulated by PTEN. The Hippo and PI3K/Akt pathways have a joint effect in regulating cell proliferation and apoptosis. Therefore, how PTEN lipid phosphatase inactivation contributes to the occurrence and development of gastric cancer and the potential role of the Hippo and PI3K/Akt pathways in PTEN lipid phosphatase inactivation mediated gastric tumorigenesis remain to be explored. Methods: Immunohistochemical staining was performed to detect the expression of p-PTEN and YAP in a gastric cancer tissue microarray. Stable cell lines expressing a wild-type or dominant-negative mutant PTEN were established. The proliferation and migration of stable cells were detected by MTT, BrdU, and colony-formation, transwell assay and high content analysis in vitro, and tumor growth differences were observed in xenograft nude mice. Changes in the expression of key molecules in the Hippo and Akt signaling pathways were detected by western blot. Nuclear-cytoplasm separation, immunofluorescence and coimmunoprecipitation analyses were conducted to explore the dysregulation of Hippo in the stable cell lines. Results: PTEN lipid phosphatase inactivation strongly promoted the proliferation and migration of gastric cancer cells in vitro and tumor growth in vivo. A immunohistochemical analysis of gastric cancer tissues revealed a significant correlation between phosphorylated PTEN and nuclear YAP expression, and both were determined to be independent prognostic factors for gastric cancer. Mechanistically, PTEN lipid phosphatase inactivation abolished the MOB1-LATS1/2 interaction, decreased YAP phosphorylation and finally promoted YAP nuclear translocation, which enhanced the synergistic effect of YAP-TEAD, thus inducing cell proliferation and migration. Moreover, PTEN lipid phosphatase inactivation promoted the PI3K/Akt pathway, and disruption of YAP-TEAD-driven transcription decreased the activation of Akt in a dose-dependent manner. Conclusions: Taken together, our findings indicate that PTEN lipid phosphatase inactivation links the Hippo and PI3K/Akt pathways to promote gastric tumorigenesis and cancer development.

PTEN Deletion Leads to Up-regulation of a Secreted Growth Factor Pleiotrophin*

Regulation of the tumor suppressor PTEN by natural anticancer compounds

Pten Modulates Cell Cycle Progression and Cell Survival by Regulating Phosphatidylinositol 3,4,5,-Trisphosphate and Akt Protein Kinase B Signaling Pathway

Inhibition of the AKT/mTOR pathway negatively regulates PTEN expression via miRNAs

PTEN regulation by Akt-EGR1-ARF-PTEN axis.

Deletion of PTEN promotes tumorigenic signaling, resistance to anoikis, and altered response to chemotherapeutic agents in human mammary epithelial cells

Pleiotrophin Enhances PDGFB-induced Gliomagenesis Through Increased Proliferation of Neural Progenitor Cells.

Essential Role of AKT-1/Protein Kinase Bα in PTEN-Controlled Tumorigenesis

Inhibition of neuronal phenotype by PTEN in PC12 cells

Conditional Loss of PTEN Leads to Precocious Development and Neoplasia in the Mammary Gland.

PTEN/PTENP1: ‘Regulating the regulator of RTK-dependent PI3K/Akt signalling’, new targets for cancer therapy

The regulation of PTEN: Novel insights into functions as cancer biomarkers and therapeutic targets

Secreted PTEN binds PLXDC2 on macrophages to drive antitumor immunity and tumor suppression

Supplementary Figures 1 Through 9 from Pseudogene PTENP1 Functions As a Competing Endogenous RNA to Suppress Clear-Cell Renal Cell Carcinoma Progression

Decoding PTEN: from biological functions to signaling pathways in tumors

PTEN Lipid Phosphatase Inactivation Links the Hippo and PI3K/Akt Pathways to Induce Gastric Tumorigenesis

PTEN C-terminal Deletion Causes Genomic Instability and Tumor Development.

PTEN, a General Negative Regulator of Cyclin D Expression

Effects of pleiotrophin (PTN) on the FAK inhibitor Y15 in breast cancer cells

Pleiotrophin is a potential colorectal cancer prognostic factor that promotes VEGF expression and induces angiogenesis in colorectal cancer

The Absence of PTEN in Breast Cancer Is a Driver of MLN4924 Resistance